Customer Service:
Mon - Fri: 8:30 am - 6 pm EST

 Historical

CLSI M48-A

Laboratory Detection and Identification of Mycobacteria; Approved Guideline

The enormous global problem with tuberculosis with roughly one-third of the worldÆs population infected with Mycobacterium tuberculosis coupled with an increasing incidence of infections caused by nontuberculous mycobacteria, present unique challenges for the laboratory diagnosis of mycobacterial infections. Not only must the diagnosis of M. tuberculosis be optimized and expedited for good patient management and institution of appropriate control measures to prevent transmission of tuberculosis, but similar demands for accurate identification of the ever-increasing numbers of species of nontuberculous mycobacteria are also pressing for the laboratory. In light of these issues, the Clinical and Laboratory Standards Institute document M48, Laboratory Detection and Identification of Mycobacteria; Proposed Guideline addresses topics related to the laboratory diagnosis of mycobacterial infections including safety and related issues, levels of service and referrals, clinical significance of mycobacteria, acceptable specimen types and their collection, transport and storage, specimen processing methods, methods for the direct detection of mycobacteria in clinical specimens, culture methods including contamination issues, reporting and quality control, and phenotypic and genotypic identification procedures.

Content Provider
Clinical And Laboratory Standards Institute [CLSI]


ANSI Logo

As the voice of the U.S. standards and conformity assessment system, the American National Standards Institute (ANSI) empowers its members and constituents to strengthen the U.S. marketplace position in the global economy while helping to assure the safety and health of consumers and the protection of the environment.

CUSTOMER SERVICE
NEW YORK OFFICE
ANSI HEADQUARTERS